在急性损伤中应用性系统:机制性见解和治疗潜力
Niraj Sunil Patil1, Vishwadeep Shelke1, Anil Bhanudas Gaikwad1
1Department of Pharmacy, Birla Institute of Technology and Science, Pilani, Pilani Campus, Rajasthan 333031, India.
Life sciences
|September 1, 2024
概括
apelinergic 系统通过减少压力和炎症来保护脏免受急性损伤 (AKI) 的承诺. 对阿佩林-13疗法的进一步研究可能为这个全球健康危机提供新的治疗方法.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 急性损伤 (AKI) 是一个重大的全球健康挑战,死亡率高,治疗选择有限.
- 辅激系统,包括apelin,elabela/toddler及其受体,表达在细胞中,并与功能有关.
- 现有研究表明,在AKI中, apelinergic系统具有脏保护作用,尽管其精确的机制和治疗潜力需要进一步研究.
研究的目的:
- 阐明 apelinergic 系统在 AKI 病理生理学的作用.
- 探索 apelinergic 系统和关键 AKI 病理机制之间的相互作用.
- 审查阿佩林-13在AKI中的治疗潜力及其临床状态.
主要方法:
- 关于 apelinergic 系统和 AKI 的研究文献综述.
- 分析 apelinergic 系统影响脏病理生理学的机制.
- 对AKI的阿佩林-13治疗的临床前和临床数据的检查.
主要成果:
- apelinergic 系统通过减少内分泌网膜 (ER) 压力,改善线粒体功能,抑制炎症和亡来缓解 AKI.
- 阿佩林通过脏血管扩张促进尿液缩,并对抗活性氧物种 (ROS).
- apelinergic 系统对 AKI 进展的确切贡献以及 apelin-13 的全部治疗潜力仍需得到充分阐明.
结论:
- apelinergic 系统通过多个途径在 AKI 中发挥着关键的保护作用.
- 阿佩林-13显示出对AKI的治疗潜力,需要进一步的临床研究.
- 了解上性系统的机制是开发新型AKI疗法的关键.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
404
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
404
Antihypertensive Drugs: Direct Renin Inhibitors
511
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
511
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
510
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
510


